Pharmaceutical Technology-03-02-2012

Pharmaceutical Technology

Pharmaceutical Technology, March 2012 Issue (PDF)

March 02, 2012

Issue PDF

36

3

Solubility : Using Nanotechnology to Tackle Key Challenges in Bioavailability

Defining Conflict of Interest

March 02, 2012

BioForum

36

3

The divide between innovation and conflict of interest in medical research is not so clear.

Genotoxic Impurities: A Q&A with Amgen's Bo Shen

March 02, 2012

Special Features

36

3

Genotoxic impurities and how to identify them and control for them have been a concern for several years in the pharmaceutical manufacturing industry. Pharmaceutical Technology spoke with Bo Shen, PhD, principal scientist at Amgen and chair of the AAPS Pharmaceutical Trace Impurities Focus Group, to gain insight on key challenges.

Inside USP: A Holistic Approach to Supply-Chain Integrity

March 02, 2012

Inside USP

36

3

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Formulation Development Forum: Programmable, Wirelessly Controlled Microchips for Drug Delivery

March 02, 2012

Pharma Ingredients

36

3

Wirelessly controlled microchips may offer an alternative to injection-based drug delivery

Generic Drug User Fees Mark a Step in the Right Direction

March 02, 2012

Viewpoint

36

3

SOCMA's Bulk Pharmaceuticals Task Force outlines key goals and challenges for user-fee legislation.